Oxford Biomedica (LSE: OXB)

Last close As at 27/09/2025

0.00 (0.00%)

Market capitalisation

Oxford Biomedica is a UK-based company with a leading position in cancer immunotherapy and gene-based products. It is focusing its efforts on two clinical programmes, ProSavin and TroVax, and has an ocular collaboration with Sanofi-Aventis.

Latest Insights

View More

Healthcare | Comment

Oxford Biomedica (LSE: OXB) revenues surge 44% 

Healthcare | Flash note

Oxford Biomedica — COVID vaccine and Kymriah news encouraging

Healthcare | edison tv

Oxford Biomedica: Edison Open House Healthcare 2022

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free